TABLE 3.
Vital signs and ISP use during procedure
| All (N = 145) | AVNRT (N = 77) | AVRT (N = 51) | AT (N = 17) | P value | |
|---|---|---|---|---|---|
| Systolic BP at baseline (mmHg) | 141 (125‐170) | 151 (110‐177) | 140 (133‐175) | 143 (114‐158) | .81 |
| Diastolic BP at baseline (mmHg) | 70 (62‐93) | 78 (54‐95) | 77 (65‐93) | 65 (62‐82) | .76 |
| HR at baseline (bpm) | 70 (62‐79) | 71 (62‐80) | 67 (62‐76) | 75 (63‐84) | .34 |
| Phenylephrine use | 75 (51%) | 42 (54%) | 23 (45%) | 9 (53%) | .57 |
| Dose of phenylephrine (mg) | 0.04 (0‐0.2) | 0.05 (0‐0.2) | 0 (0‐0.2) | 0.1 (0‐0.2) | .74 |
| ISP use for induction | 129 (89%) | 71 (92%) | 43 (84%) | 15 (88%) | .38 |
| ISP dose for induction (mg/h) | 0.06 (0.03‐0.06) | 0.06 (0.03‐0.06) | 0.03 (0.02‐0.06) | 0.06 (0.06‐0.12) | .0013 |
Abbreviations: BP, blood pressure; HR, heart rate; ISP: isoproterenol.
Values less than 0.05 are written in bold.